40 years after the Chernobyl nuclear power plant accident. Development and application of retrospective dosimetry technologies for uncontrolled radiation exposure of the population and subsequent conversion of these technologies for use in oncoradiology: a brief analytical review

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.21870/0131-3878-2026-35-2-207-226
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article briefly describes: a) the role and place of computational and instrumental methods of retrospective dosimetry, developed and implemented with the participation of specialists from the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, in assessing the consequences of the Chernobyl accident for the population living in the territories of the Russian Federation contaminated with radionuclides; b) the subsequent development of retrospective dosimetry technologies in application to oncoradiology – for in vivo dosimetry in brachytherapy of malignant tumors of various localizations and for dosimetry of internal irradiation of tumor formations and organs at risk during radionuclide therapy. This brief analytical review demonstrates the conversion of retrospective dosimetry methods developed in response to the extreme challenges of a large-scale radiological accident into instrumental and computational technologies for dosimetry of foci and organs at risk in patients, intended for systematic use in oncoradiology – with the aim of providing dosimetric guarantees of the quality and safety of brachytherapy and radionuclide therapy methods for malignant neoplasms.